Kirkland, Canada

Danbing Ke

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Danbing Ke

Introduction

Danbing Ke is a notable inventor based in Kirkland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of bacterial compositions with therapeutic applications. With a total of 4 patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

Danbing Ke's latest patents focus on bacterial ribonucleic acid cell wall compositions and methods of making and using them. These inventions relate to novel bacterial and mycobacterial compositions that contain RNA and cell walls. The methods developed for these compositions are designed to stimulate the immune system and exhibit anti-cancer activity. This innovative approach could pave the way for new therapeutic strategies in combating various diseases.

Career Highlights

Throughout his career, Danbing Ke has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Bioniche Urology IP Inc. and Telesta Therapeutics IP Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in his field.

Collaborations

Danbing Ke has collaborated with several professionals in his field, including Nigel C Phillips and Zdenek Richard Holan. These collaborations have likely enriched his research and expanded the scope of his innovations.

Conclusion

Danbing Ke's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work in developing bacterial compositions with immune-stimulating and anti-cancer properties showcases the potential for innovative solutions in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…